Terry Murdock
Geschäftsführer bei G1 THERAPEUTICS, INC.
Vermögen: 368 580 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jack Bailey | M | 59 | 4 Jahre | |
| Monica Thomas | F | - | 1 Jahre | |
| W. Staub | M | 61 | 8 Jahre | |
| Ari Bousbib | M | 63 | 8 Jahre | |
| Garry Nicholson | M | 69 | 6 Jahre | |
| Jacks Lee | M | 60 | 2 Jahre | |
| James Berkshire | M | 51 | 7 Jahre | |
| Alicia Secor | F | 62 | 3 Jahre | |
| Norman Sharpless | M | 57 | 2 Jahre | |
| John Danhakl | M | 67 | 8 Jahre | |
| Cynthia Flowers | F | 64 | 6 Jahre | |
| William C. Roberts | M | 54 | 3 Jahre | |
| Todd Sisitsky | M | 52 | 8 Jahre | |
| John Leonard | M | 66 | 9 Jahre | |
| Jim Fasano | M | 54 | 8 Jahre | |
| Glenn Muir | M | 65 | 9 Jahre | |
| Andrew Beelen | M | - | - | |
| Andrew Perry | M | 51 | 3 Jahre | |
| Trudy Stein | F | - | 8 Jahre | |
| Rajesh K. Malik | M | 65 | 10 Jahre | |
| Mark Avagliano | M | 48 | 5 Jahre | |
| Michael Stibilj | M | 55 | 7 Jahre | |
| John Umstead | M | - | 6 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jay C. Strum | M | - | 11 Jahre | |
| Seth A. Rudnick | M | 75 | 7 Jahre | |
| Christy Shaffer | M | 66 | 6 Jahre | |
| Mark Velleca | M | 60 | 9 Jahre | |
| Glenn C. Rice | M | 68 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 Jahre |
| Jeff Macdonald | M | - | 3 Jahre | |
| Darcie Peck | F | 66 | 14 Jahre | |
| Andrew Witty | M | 59 | 3 Jahre | |
| Marla Kessler | F | - | - | |
| Tyrell J. Rivers | M | 51 | 1 Jahre | |
| James Hanson | M | 52 | - | |
| Gregory J. Mossinghoff | M | - | 3 Jahre | |
| James Erlinger | M | 65 | 2 Jahre | |
| Fred Eshelman | M | 76 | 6 Jahre | |
| Ronald Rittenmeyer | M | 76 | 6 Jahre | |
| Willie Deese | M | 68 | 4 Jahre | |
| Richard L. Love | M | 81 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 10 Jahre |
| Shannon Morris | M | 54 | 3 Jahre | |
| Donna Kralowetz | F | 53 | 2 Jahre | |
| Melissa Beelen | F | - | 5 Jahre | |
| Richie Etwaru | M | - | 3 Jahre | |
| Tal Rosenberg | M | - | - | |
| Soma Gupta | F | - | 1 Jahre | |
| David D. Elks | M | - | 3 Jahre | |
| Shannon Morris | M | - | 3 Jahre | |
| Joanne Zellner | F | - | 1 Jahre | |
| Lisa van Capelle | F | - | 12 Jahre | |
| Ostra Jewell | F | - | - | |
| Jason S. Fisherman | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Mark E. Watson | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Alexander D. Smith | M | - | 6 Jahre | |
| John Demaree | M | 56 | 2 Jahre | |
| Ronald G. Tefteller | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Mark P. Mellin | M | 62 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 Jahre |
| Victor Micati | M | 83 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Steven D. Weitman | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Joy Amundson | F | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 2 Jahre |
| Gary V. Woods | M | 80 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Joseph Bailes | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Barclay Phillips | M | 61 | 2 Jahre | |
| Gregory Weaver | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 Jahre |
| Chandra D. Lovejoy | F | 52 | 4 Jahre | |
| Jeffrey H. Buchalter | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 Jahre |
| Timothy M. Ruane | M | 59 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 Jahre |
| Craig Tooman | M | 58 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 Jahre |
| Fred Cohen | M | 67 | 8 Jahre | |
| Michael McDonnell | M | 60 | 5 Jahre | |
| J. Edwards | M | 57 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 1 Jahre |
| Corey Levenson | M | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 8 Jahre |
| Lisa Benna | F | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 73 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Terry Murdock
- Persönliches Netzwerk
